Junqing Shen

4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6.

Rajiv Chopra, Sunkyu Kim, Ming Xu, 2010, Journal of medicinal chemistry.

Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule

Dietmar Hoffmann, Jean-Pierre Marquette, Magali Mathieu, 2014, The Journal of Biological Chemistry.

Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors.

Paul N. Mortenson, M. Congreve, R. Cheng, 2012, ACS medicinal chemistry letters.

Metal Binding Network by an Allosteric Dehydrogenase 1 ( IDH 1 ) via Disruption of Selective Inhibition of Mutant Isocitrate Enzymology

S. Gross, Q. Gao, D. Wiederschain, 2014 .

Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides.

Chen Yang, Yong-mei Shen, Xiao-chun Yang, 2008, World journal of gastroenterology.

Abstract A226: Mechanism of action of iniparib: Stimulation of reactive oxygen species (ROS) production in an iniparib-sensitive breast cancer cell line.

D. Bergstrom, J. Watters, J. Pollard, 2011 .

Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections

J. Mascola, M. Connors, R. Koup, 2023, Nature communications.

Calcium phosphate-based nanomedicine mediated CRISPR/Cas9 delivery for prostate cancer therapy

Langli Wei, Rui Zhang, Yong Wang, 2022, Frontiers in Bioengineering and Biotechnology.